Mark J. Pettenati

8.2k citations
150 papers · 5.6k · 1 hit paper · h-index 40

Impact in

  • Hematology top 0.2%
    • Acute Myeloid Leukemia Research
    • Chronic Myeloid Leukemia Treatments
    • Hematopoietic Stem Cell Transplantation
  • Genetics top 1%
    • Genomic variations and chromosomal abnormalities
    • Myeloproliferative Neoplasms: Diagnosis and Treatment

Papers in

    • Retinoids in leukemia and cellular processes 6
    • Acute Myeloid Leukemia Research 40
    • Chronic Myeloid Leukemia Treatments 16

Mark J. Pettenati

147 papers receiving 5.3k citations

Mark J. Pettenati's Hit Papers

Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype. 1998 · 544 citations
5440+9+18Years since publication100200300400500

Peers

Mark J. Pettenati
Comparison fields: 5 of 135
  • Hematology 2.3k
  • Genetics 584
  • Public Health, Environmental and Occupational Health 1.1k
  • Genetics 1.1k
  • Pediatrics, Perinatology and Child Health 586
Replace Bertil Johansson with:
Bertil Johansson Sweden
Ilan R. Kirsch United States
Athena M. Cherry United States
Tracy Chaplin United Kingdom
Anna Savoia Italy
Carine Munaut Belgium
Jan Cools Belgium
Arleen D. Auerbach United States
Miikka Vikkula Belgium
Neil V. Morgan United Kingdom
Mark J. Pettenati relative to Bertil Johansson Sweden Bertil Johansson's profile →
Citations per field
00.5×1.5×
Bertil Johansson · 1×
Citations per year

Countries citing papers authored by Mark J. Pettenati

Since Specialization
Citations

This map shows the geographic impact of Mark J. Pettenati's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark J. Pettenati with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark J. Pettenati more than expected).

Fields of papers citing papers by Mark J. Pettenati

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark J. Pettenati. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark J. Pettenati. The network helps show where Mark J. Pettenati may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark J. Pettenati, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark J. Pettenati Line = papers co-authored together Mark J. Pettenati links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 150 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype.
Hit paper breakdown →
1998544
2 2005278
3 2006264
4 1999256
5 1986250
6 2004169
7 1987139
8 2001136
9 2006135
10 1999123
11 1995108
12 200499
13 200199
14 199598
15 199798
16 200197
17 200191
18 198990
19 200485
20 200483

About Mark J. Pettenati

Mark J. Pettenati is a scholar working on Molecular Biology, Hematology, Genetics, Public Health, Environmental and Occupational Health and Pediatrics, Perinatology and Child Health, having authored 150 papers that have together received 5.6k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (40 papers), Genomic variations and chromosomal abnormalities (17 papers), Prenatal Screening and Diagnostics (17 papers), Chronic Myeloid Leukemia Treatments (16 papers), Acute Lymphoblastic Leukemia research (15 papers), Chromosomal and Genetic Variations (12 papers), Sarcoma Diagnosis and Treatment (9 papers) and Retinoids in leukemia and cellular processes (6 papers). The work is most often cited by research in Hematology (2.3k citations), Genetics (584 citations), Public Health, Environmental and Occupational Health (1.1k citations), Genetics (1.1k citations) and Pediatrics, Perinatology and Child Health (586 citations). Mark J. Pettenati has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Andrew J. Carroll, Clara D. Bloomfield, P. Nagesh Rao, Robert J. Mayer, Richard A. Larson, Krzysztof Mrózek, Charles A. Schiffer, Ramana Tantravahi, Frederick R. Davey and John C. Byrd. Their work appears in journals such as Genomics, Blood, Prenatal Diagnosis, Journal of Clinical Oncology and Archives of Pathology & Laboratory Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact